Prologis, Inc. (PLD) had a light trading with around 2.59M shares changing hands compared to its three month average trading volume of 2.69M. The stock traded between $49.45 and $50.44 before closing at the price of $50.12 with 1.44% change on the day. The San Francisco California 94111 based company is currently trading 43.44% above its 52 week low of $37.02 and -7.78% below its 52 week high of $54.87. Both the RSI indicator and target price of 47.38 and $15.46 respectively, lead us to believe that it should be put on hold over the coming weeks.
Prologis Inc. is an independent equity real estate investment trust. It invests in the real estate markets across the globe. The firm engages in the ownership, development, management, and leasing of industrial distribution and retail properties. It was previously known as Security Capital Investment Trust. Prologis Inc. was formed in 1991 and is based in San Francisco, California with an additional office in Denver, Colorado.
Centene Corporation (CNC) failed to extend gains with the stock declining -1.93% or $-1.38 to close the day at $70.07 on active trading volume of 2.57M shares, compared to its three month average trading volume of 1.74M. The St. Louis Missouri 63105 based company has been outperforming the health care plans group over the past 52 weeks, with the stock gaining 25.3%, compared to the industry which has advanced 15.75% over the same period. With RSI of 70.7, the stock should still continue to rise and get closer to its one year target estimate of $77.76, making it a hold for now.
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers Medicaid and Medicaid-related health plan coverage to individuals through government subsidized programs, including Medicaid, the State children’s health insurance program, long-term care, foster care, and dual-eligible individual, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and x-ray services, home health and durable medical equipment, behavioral health and substance abuse, 24-hour nurse advice line, transportation assistance, vision care, dental care, immunizations, prescriptions and limited over-the-counter drugs, specialty pharmacy, therapies, social work services, and care coordination. The Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; vision services; dental services; correctional healthcare services; in-home health services; and integrated long-term care services, as well as care management software that automate the clinical, administrative, and technical components of care management programs. This segment offers its services and products to state programs, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Agilent Technologies, Inc. (A) shares were down in last trading by -1.51% to $50.84. It experienced higher than average volume on day. The stock increased in value by almost 0.73% over the past week and grew 5.37% in the past month. It is currently trading 6.91% above its 50 day moving average and 10.77% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -1.93% decrease in value from its one year high of $51.84. The RSI indicator value of 64.22, lead us to believe that it is a hold for now.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Its Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The company’s Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. Its Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, and compliance support, as well as asset management and consultation services. The company markets and sells its products through direct sales, electronic commerce, resellers, manufacturers’ representatives, and distributors. It has a collaboration agreement with University of Leuven to focus on detecting genetic abnormalities in cell-free DNA and embryo biopsies. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.